Sanofi-Aventis Signs Global Software Agreement with Desert Scientific Software

Sanofi-Aventis, the world’s 3rd largest pharmaceutical company, has licensed Proasis2®, Desert Scientific Software’s protein structure database and visualization system.

Desert Scientific Software (DesertSci), a chemo/bioinformatics software company based in Sydney, Australia is pleased to announce the global licensing of their flagship product, Proasis2®, by Sanofi-Aventis. The collaboration includes an on-going development agreement that promises to deliver further enhancements and exciting new features to the system.

Proasis2® delivers the industry’s best protein structure database and visualisation system for medicines research. In one complete system it combines a superior relational database for storing, retrieving, and searching structures important to medicinal chemistry projects with the most intuitive desktop visualization system for exploring those structures. Developed in collaboration with a number of global pharmaceutical companies, Proasis2® matches the real requirements of leading edge drug discovery. It empowers medicinal chemists to explore ideas themselves and significantly frees up crystallographers and modellers time so that they can concentrate on their own sophisticated problems in drug discovery.